Q2 2024 Adjusted EBITDA 7% above Q2 2023; Improvement in gross margin and adjusted EBITDA margin in Q2 & H1 2024 following strict inventory management allowing the Company to benefit from market costs, positive product sales mix and continued OPEX management measures; Significant improvement in cash flow despite challenging market conditions; Positive operating cash flow of $243 million achieved in H1 2024 in comparison to a negative cash flow of $19 million in H1 2023; Positive free cash flow of $51m achieved in H1 2024 in comparison to a negative cash flow of $254m in H1 2023; Implementation of transformation plan underway, showing initial benefits as challenging market conditions continue.

Second Quarter 2024 Highlights: Sales down 16% to $1,041 million ( -14% in RMB terms ; -14% in CER [1] terms), mainly reflecting a 10% decrease in prices and a 4% decrease in volumes ; -14% in CER terms), mainly reflecting a 10% decrease in prices and a 4% decrease in volumes Gross profit amounted to $269m (margin of 25.8%) vs $277m (margin of 22.5%) in Q2 2023 Adjusted EBITDA amounted to $120 million (margin of 11.5%) vs. $112 million (margin of 9.1%) in Q2 2023 Adjusted net loss of $61 million; Reported net loss of $94 million Operating cash flow of $347million in Q2 2024 vs $405 million in Q2 2023

Free cash flow of $245 million in Q2 2024 vs $288 million in Q2 2023 First Half Year 2024 Highlights: Sales down 16% to $2,098 million ( – 14 % in RMB terms ; -14% in CER terms), mainly reflecting a 10% decrease in prices and a 4% decrease in volumes ; -14% in CER terms), mainly reflecting a 10% decrease in prices and a 4% decrease in volumes Gross profit amounted to $557m (margin of 26.5%) vs $617m (margin of 24.8%) in H1 2023 Adjusted EBITDA amounted to $252 million (margin of 12.0%) vs. $277 million (margin of 11.1%) in H1 2023

Adjusted net loss of $71 million; Reported net loss of $126 million Improvement of $262 million in operating cash flow; $243 million in H1 2024 vs – $19 million in H1 2023 Improvement of $305 million in free cash flow; $51 million in H1 2024 vs – $254 million in H1 2023 BEIJING and TEL AVIV, Israel, Aug. 28, 2024 /PRNewswire/ — ADAMA Ltd. (the “Company”) (SZSE: 000553), today reported its financial results for the second quarter and first half of 2024 that ended June 30, 2024. Steve Hawkins, President and CEO of ADAMA, said, “While the crop protection market remains challenging, we are focused on our transformation plan aimed at improving the quality of our business and strengthening our position in the fast-growing Value Innovation customer segment. We continue to launch a wide array of advanced, differentiated products with strong ROI for farmers in our largest and most important markets. The agriculture industry is cyclical in nature and ADAMA is taking the necessary steps to maximize our ability to capture opportunities when the market turns around. We believe that our value innovation portfolio is exactly the right fit for the large segment of growers who are looking for innovation but will be pressured by declining commodity prices and seeking cost effective solutions.

“Our transformation plan is already showing initial positive results with higher EBITDA achieved in the second quarter, as well as an improvement in the gross and EBITDA margins in both the second quarter and the first half of 2024. This improvement was driven by efficient inventory management, better product sales mix as well as a steady reduction in operating expenses. Steps taken in working capital and CAPEX management have brought a significant improvement in cashflow in the first half of 2024. “We are still in the first phase of our transformation in ADAMA and as the market eventually turns around, we expect to see significant acceleration of the plan’s impact on our financial results.”

Table 1. Financial Performance Summary USD (m) As Reported Adjustments Adjusted Q2 202 4 Q2 202 3 % Change Q2 202 4 Q2 202 3 Q2 202 4 Q2 202 3 % Change Revenues 1,041 1,233 (16 %) – – 1,041 1,233 (16 %) Gross profit 227 253 (10 %) 41 24 269 277 (3 %) % of sales 21.8 % 20.6 % 25.8 % 22.5 % Operating income (EBIT) (16) 40 69 6 52 46 13 % % of sales (1.6 %) 3.3 % 5.0 % 3.8 % Loss before taxes (59) (56) 6 % 42 6 (17) (50) (65 %) % of sales (5.7 %) (4.5 %)

(1.7 %) (4.0 %) Net loss (94) (46) 102 % 33 5 (61) (41) 48 % % of sales (9.0 %) (3.8 %) (5.8 %) (3.3 %) EPS – USD (0.0403) (0.0199) (0.0261) (0.0177) – RMB (0.2864) (0.1397) (0.1855) (0.1238) EBITDA 76 115 (34 %) 44 (3) 120 112 7 % % of sales 7.3 % 9.3 % 11.5 % 9.1 % USD (m) As Reported Adjustments Adjusted H1 202 4 H1 202 3 % Change H1 202 4 H1 202 3 H1 202 4 H1 202 3 % Change Revenues 2,098 2,492 (16 %) – – 2,098 2,492 (16 %) Gross profit 484 563 (14 %) 73 54 557 617 (10 %) % of sales 23.0 % 22.6 %

26.5 % 24.8 % Operating income (EBIT) 34 132 (74 %) 89 16 124 148 (16 %) % of sales 1.6 % 5.3 % 5.9 % 5.9 % Loss before taxes (80) (45) 78 % 65 16 (16) (29) % of sales (3.8 %) (1.8 %) (0.7 %) (1.2 %) Net loss (126) (34) 268 % 55 15 (71) (20) % of sales (6 %) (1.4 %) (3.4 %) (0.8 %) EPS – USD (0.0541) (0.0147) (0.0303) (0.0084) – RMB (0.3841) (0.1039) (0.2152) (0.0604) EBITDA 196 281 (30 %) 55 (4) 252 277 (9 %) % of sales 9.4 % 11.3 %

The summary provided is a table of financial ratios for a company. The table shows the company’s profitability, liquidity, and solvency ratios. **Detailed Analysis:**

**Profitability:**

* **Gross Profit Margin:** This ratio measures the percentage of revenue remaining after deducting the cost of goods sold.

* The company’s basic and diluted earnings per share (EPS) for Q2 and H1 2024 and 2023 are calculated using 2,329.8 million shares. * The company’s financial statements are presented in a table format. * The table may not sum due to rounding.

Update on the War Situation in Israel ADAMA is headquartered in Israel and has three manufacturing sites in the country. Following October 7 th, 2023, the Company continued the production in its global manufacturing sites and in Israel, with certain non-significant restrictions (which have been lifted in February 2024). This situation did not have a material impact on the Company’s ability to support its markets or on ADAMA’s consolidated financial results. On the 14th of April, Israel was under an attack from Iran, with no consequences to the Company’s ongoing activities. Update on Impact of Shipping Obstructions In January 2024 some major shipping lines announced that they will suspend shipping to Israel through Israeli ports and through the Suez Canal due to tensions in the Red Sea. This has led to longer transportation times, with shipping lines being diverted around Africa.

Shipping time and costs have increased significantly, mainly in the China – Israel / Europe; China-America routes in comparison to before January 2024. **Detailed Text:**

The global shipping industry has been grappling with a surge in costs and delays, impacting businesses and consumers alike. This trend has been particularly pronounced in specific trade routes, with the China-Israel/Europe and China-America routes experiencing the most significant increases.

Portfolio Development Update Product Launches, Registrations: During the second quarter of 2024 ADAMA continued to register and launch multiple new products in markets across the globe, adding on to its differentiated product portfolio. Differentiated products address specific grower needs through innovative formulation technology and/or novel mixing concepts of Active Ingredients. Select launches of differentiated products during the second quarter of 2024 include: Launch of Prothioconazole based products, part of ADAMA’s comprehensive portfolio of innovative solutions for cereal fungicides – Protadis® and Magan® in Turkey , powered by ADAMA’s proprietary Asorbital® Formulation Technology- – Maxentis® in Australia Vinergy® in Italy and France – a unique combination of folpet, a protectant fungicide with multi-site contact activity and potassium phosphonate, a systemic fungicide rapidly distributed in the whole plant. The combination of both active ingredients ensures long lasting plant protection against downy mildew.

Selected registrations of differentiated products during the second quarter of 2024 include: Registration of Prothioconazole based products, part of ADAMA’s comprehensive portfolio of innovative solutions for cereal fungicides in Europe, including: – Soratel® in Spain, Hungary, Moldova, Slovenia and Slovakia & Morocco powered by ADAMA’s proprietary Asorbital® Formulation Technology – Avastel® in France, Poland and Latvia, powered by ADAMA’s proprietary Asorbital® Formulation Technology – Maganic® in Italy and Slovakia, powered by ADAMA’s proprietary Asorbital® Formulation Technology – Forapro® in Slovakia and Lithuania, powered by ADAMA’s proprietary Asorbital® Formulation Technology- Maxentis® in Spain, Italy, Hungary, Romania and Greece & Moldova, a dual mode broad spectrum fungicide

Registration of Edaptis ® in Poland. EDAPTIS® is a ready-to-use solution that provides broad-spectrum control of grassy weeds and improved efficacy in combating resistant populations. in Poland. EDAPTIS® is a ready-to-use solution that provides broad-spectrum control of grassy weeds and improved efficacy in combating resistant populations. Registration of Bazak ® in India. BAZAK® is a new strong solution helping farmers controlling brown plant hoppers in rice thanks to the combination of 2 systemic molecules (Pymetrozine and Dinotefuran) having different mode of actions. in India. BAZAK® is a new strong solution helping farmers controlling brown plant hoppers in rice thanks to the combination of 2 systemic molecules (Pymetrozine and Dinotefuran) having different mode of actions. Registration of Forpido ® in India – FORPIDO ® is an innovative insecticide combining Chlorantraniliprole, Fipronil and Zinc that controls resistant rice stem borer and improves early crop establishment.

in India – FORPIDO is an innovative insecticide combining Chlorantraniliprole, Fipronil and Zinc that controls resistant rice stem borer and improves early crop establishment. Folpet & Captan active ingredient renewal in Europe , supporting the ongoing marketing of Folpan® 500SC, Folpan® 800WG and Merpan® 800WG Select patent granted during the second quarter of 2024 includes: Patent granted for Sesgama ® in EU , a proprietary formulation technology platform for high-load and other challenging formulations, enabling less use of co-formulants, transport and packaging materials per acre treated with a resulting improved product sustainability profile. First products expected to be launched in the coming years in EU.

* **Proprietary Formulation Technology Platform:** This platform is the foundation for the company’s innovation and product development. It allows for the creation of high-load and other challenging formulations. * **Reduced Co-formulants and Packaging Materials:** The platform’s unique capabilities enable the company to use less co-formulants and packaging materials, leading to a more sustainable product profile.

The summary provided details the financial performance of a company in the first half of 2024. The company experienced a decline in revenue, primarily driven by a decrease in both prices and volumes. **Detailed Text:**

The financial performance of the company during the first half of 2024 paints a picture of a challenging market environment.

* **EAME Sales Decline: A Multifaceted Challenge**
* **EAME Sales:

* Sales in Europe, Africa & Middle East (EAME) decreased in the second quarter and first half of 2024. * Demand recovered in Europe at the farmer level in the first half. * The decline in sales was attributed to a combination of factors, including supply chain disruptions, rising input costs, and a weakening global economic outlook.

In the US Ag market, sales declined in the second quarter and first half of 2024 reflecting overall good weather, with the season progressing as usual, while new competition from China and India is putting pressure on pricing. Channel inventory levels have declined with purchasing patterns on a just-in-time basis. Pricing is currently stabilizing, although still lower than during H1 2023. ?ADAMA’s sales in Canada declined in the second quarter and first half of 2024 reflecting low insecticide sales as weather conditions were unfavorable for insect pressure. While inventory levels are declining, mainly in herbicide and fungicides, purchasing patterns on a just-in-time basis. Additionally, the market experienced strong ?competition and softer pricing particularly in commoditized products.

Latin America: Brazil – decline in sales in the second quarter and first half of 2024, reflecting the softer pricing, competition from Chinese competitors, “wait and see” famers behavior postponing CP purchases, as well as de-focus from non-selective herbicides. ?Channel inventory has mostly normalized however demand is impacted by ?expectations for additional price decreases. ?The Company is focusing its sales on higher margin products, with new product introductions of differentiated products continuing to do well. In the rest of LATAM lower sales reflected the overall ?contraction in the market in Northern LATAM negatively impacted by El Niño ?weather. Inventory levels are back to normal levels in most countries, while pricing was impacted by high competition, mostly in commoditized products.

Asia-Pacific (APAC): In China , the branded formulations sales in the second quarter and first half of 2024 were impacted by pressure on pricing and negative weather in southern China while focusing on improving the quality of the business with differentiated products. High channel inventories especially for cash crops. In the non-ag business, market pricing in has normalized while tech sales were mainly impacted by a “wait and see” approach in the market. In the Pacific region, sales declined impacted by softer pricing following competition from China and India. Despite this, better weather conditions than expected brought an increase in demand, mainly in Pacific countries in the second quarter of 2024. While channel inventories have declined, purchasing patterns are on a just-in-time basis.

Sales in India were impacted by overall negative season with erratic weather and low pest pressure and softer pricing, particularly in ?commoditized products. Channel inventories have increased due to the weak season. Sales in the wider APAC region continued to experience pricing pressure following intense competition from China, particularly in commoditized products, while good weather conditions supported demand. Gross Profit reported in the second quarter reached $227 million (gross margin of 21.8%) compared to $253 million (gross margin of 20.6%) in the same quarter last year, and reached $484 million (gross margin of 23.0%) in the half year period compared to $563 million (gross margin of 22.6%) last year.

* **Adjusted Gross Profit:** This is a measure of profitability that excludes certain expenses and adjustments to the reported gross profit. It’s a way to get a clearer picture of the company’s core operating performance.

Operating expenses reported in the second quarter of 2024 were $244 million (23.4% of sales), compared to $213 million (17.3% of sales) in the same quarter last year and reached $449 million (21.4% of sales) in the half year period compared to $431 million (17.3% of sales) last year. Adjustments to reported results : please refer to the explanation regarding adjustments to the gross profit in respect to certain transportation costs, taxes and surcharges and inventory impairment. Additionally, the Company recorded certain non-operational items within its reported operating expenses amounting to $56 million in Q2 2024 in comparison to $6 million in Q2 2023 and $76 in H1 2024 in comparison to $15 in H1 2023. These include mainly (i) provisions, such as legal claims, registration impairment and update of registration depreciation (ii) measures to improve efficiencies, (iii) non-cash amortization charges in respect of Transfer Assets received from Syngenta related to the 2017 ChemChina-Syngenta acquisition, (iv) charges related to the non-cash amortization of intangible assets created as part of the Purchase Price Allocation (PPA) on acquisitions, with no impact on the ongoing performance of the companies acquired. For further details on these non-operational items, please see the appendix to this release.

8% of total sales) in Q2 2017. This decrease in operating expenses is attributed to several factors, including:

The company’s second quarter results showed a significant improvement in operating income. This improvement was driven by several factors, including a strong sales performance, cost-cutting measures, and a favorable market environment. **Detailed Analysis:**

The company’s second quarter operating income reached $52 million, representing a 5.0% margin on sales.

Adjusted financial expenses amounted to $70 million in the second quarter, compared to $96 million in the corresponding quarter last year and amounted to $139 million in the half year period compared to $177 million last year. The lower financial expenses were mainly due to lower hedging costs on exchange rates, the net effect of lower Israeli CPI on the ILS-denominated, CPI-linked bonds? (in the half year period) and steps taken by the Company’s management to optimize the Company’s financing structure. These steps included taking advantage of the high interest rate environment to increase interest received from weekly bank deposits designated to support working capital, as well as improving financing terms and leveraged group funding possibilities by taking long-term RMB denominated loans at attractive rates, which minimized the increase in bank interest expenses paid.

Adjusted taxes on income in the second quarter amounted to tax expenses of $43 million, compared to a tax income of $8 million in the corresponding quarter last year and amounted to an expense of $55 million in the half year period compared to a tax income of $10 million last year. Despite reaching losses before tax, the Company recorded tax expenses mainly ?because the losses were primarily incurred by subsidiaries with relatively lower tax rates, while some ?of them did not create deferred tax assets on the losses. On the other hand, the subsidiaries that ?generated profit have a higher tax rate. ?

In the first half of 2024 the company recorded tax expenses due to the non-?cash impact of the weakness of the BRL compared with tax income due to stronger BRL in the first ?half of 2023. ? Net loss reported in the second quarter was $94 million and $126 million in the half-year period, compared to a net loss of $46 million and $34 million in the corresponding periods last year, respectively. Adjusted net loss in the second quarter was $61 million and $71 million in the half-year period, compared to a net loss of $41 million and $20 million in the corresponding periods last year, respectively.

The decrease in working capital is a significant development that warrants further investigation.

Cash Flow: Operating cash flow of $347 million and $243 million was generated in the second quarter and first half year period in 2024 respectively, compared to $405 million generated in the second quarter and $19 million consumed in the half year period in 2023. The operating cash flow was significantly improved in the first half year of 2024 due to the company maintaining strict procurement practices, intensive collections and an improvement in supplier terms, reflecting initial implementation of initiatives taken as part of the company’s transformation plan. In the second quarter we see a decrease in operating cash flow, reflecting the high benchmark in Q2 2023 following the significant decrease in procurement in that quarter.

Net cash used in investing activities was $48 million in the second quarter and $115 million in the first half period in 2024, compared to $69 million and $162 million in the corresponding periods last year, respectively. The lower cash used in investing activities in the second quarter and first half of 2024 reflected the prioritization of fixed asset investments in its manufacturing facilities as well as optimization of the company’s portfolio, part of the implementation of the Company’s transformation plan, reflected in prioritization of investments in intangible assets relating to ADAMA’s global registrations. It should be noted that in the first quarter of 2023 the company completed the acquisition of AgriNova New Zealand.

Free cash flow of $245 million was generated in the second quarter and $51 million generated in the half-year period compared to $288 million generated in the second quarter and $254 million consumed in the corresponding periods last year, respectively, reflecting the aforementioned operating and investing cash flow dynamics. Table 3. Revenues by operating segment Sales by segment Q2 2024 USD (m) % Q2 2023 USD (m) % H1 2024 USD (m) % H1 2023 USD (m) % Crop Protection 945 91 % 1,145 93 % 1,906 91 % 2,291 92 % Intermediates and Ingredients 96 9 % 89 7 % 192 9 % 201 8 % Total 1,041 100 % 1,233 100 % 2,098 100 % 2,492 100 %

Sales by product category Q2 2024 USD (m) % Q2 2023 USD (m) % H1 2024 USD (m) % H1 2023 USD (m) % Herbicides 414 40 % 528 43 % 868 41 % 1,104 44 % Insecticides 304 29 % 352 29 % 594 28 % 686 28 % Fungicides 227 22 % 264 21 % 444 21 % 502 20 % Intermediates and Ingredients 96 9 % 89 7 % 192 9 % 201 8 % Total 1,041 100 % 1,233 100 % 2,098 100 % 2,492 100 % Notes: The sales split by product category is provided for convenience purposes only and is not representative of

**ADAMA: A Global Force in Protecting Our Food Supply**

**ADAMA:

is a global leader in the development, manufacturing, and marketing of crop protection solutions. ADAMA is a publicly traded company listed on the Tel Aviv Stock Exchange (TASE) under the ticker symbol “ADMA”. ADAMA’s mission is to empower farmers and contribute to global food security.

Contact Rivka Neufeld Zhujun Wang Global Investor Relations China Investor Relations Email: [email protected] Email: [email protected] Abridged Adjusted Consolidated Financial Statements The following abridged consolidated financial statements and notes have been prepared as described in Note 1 in this appendix. While prepared based on the principles of Chinese Accounting Standards (ASBE), they do not contain all of the information which either ASBE or IFRS would require for a complete set of financial statements, and should be read in conjunction with the consolidated financial statements of both ADAMA Ltd. and Adama Agricultural Solutions Ltd. as filed with the Shenzhen and Tel Aviv Stock Exchanges, respectively.

The company’s financial performance is being analyzed in the context of its recent earnings release. The release provides a detailed breakdown of the company’s income statement, including both reported and adjusted figures. The adjusted figures are presented to provide a clearer picture of the company’s core operating performance. **Detailed Text:**

The company’s earnings release offers a comprehensive analysis of its financial performance, going beyond the standard reported figures.

Abridged Consolidated Income Statement for the First Half of 2024 Adjusted [5] H1 2024 USD (m) H1 2023 USD (m) H1 2024 RMB (m) H1 2023 RMB (m) Revenues 2,098 2,492 14,910 17,253 Cost of Sales 1,536 1,852 10,915 12,827 Other costs 6 22 39 157 Gross profit 557 617 3,956 4,270 % of revenue 26.5 % 24.8 % 26.5 % 24.7 % Selling & Distribution expenses 338 371 2,401 2,568 General & Administrative expenses 69 69 487 475 Research & Development expenses 31 38 218 263 Other operating expenses (income) (4) (8) (30) (56) Total operating expenses 433 469 3,076 3,249 % of revenue 20.6 % 18.8 % 20.6 % 18.8 % Operating income (EBIT) 124 148 880 1,021 % of revenue 5.9 % 5.9 % 5.9 % 5.9 % Financial expenses 139 177 990 1,228 Loss before taxes (16) (29) (110) (207) Taxes on Income 55 (10) 391 (67) Net loss (71) (20) (501) (141) % of revenue (3.4 %) (0.8 %) (3.4 %) (0.8 %) Adjustments 55 15 393 101 Reported Net loss (126) (34) (895) (242) % of revenue (6 %) (1.4 %) (6 %) (1.4 %) Adjusted EBITDA 252 277 1,789 1,914 % of revenue 12.0 % 11.1 % 12.0 % 11.1 % Adjusted EPS[6] – Basic (0.0303) (0.0084) (0.2152) (0.0604) – Diluted (0.0303) (0.0084) (0.2152) (0.0604) Reported EPS[6] – Basic (0.0541) (0.0147) (0.3841) (0.1039) – Diluted (0.0541) (0.0147) (0.3841) (0.1039)

Abridged Consolidated Balance Sheet June 30 2024 USD (m) June 30 2023 USD (m) June 30 2024 RMB (m) June 30 2023 RMB (m) Assets Current assets: Cash at bank and on hand 561 637 3,995 4,605 Bills and accounts receivable 1,314 1,421 9,368 10,264 Inventories 1,728 2,307 12,316 16,668 Other current assets, receivables and prepaid expenses 279 269 1,986 1,941 Total current assets 3,882 4,633 27,665 33,478 Non-current assets: Fixed assets, net 1,754 1,747 12,499 12,624 Rights of use assets 81 89 576 641 Intangible assets, net 1,407 1,472 10,027 10,634 Deferred tax assets 203 244 1,449 1,760 Other non-current assets 89 106 638 766 Total non-current assets 3,534 3,657 25,189 26,424 Total assets 7,416 8,290 52,854 59,902

Liabilities Current liabilities: Loans and credit from banks and other lenders 928 1,236 6,611 8,934 Bills and accounts payable 761 892 5,424 6,442 Other current liabilities 794 948 5,659 6,853 Total current liabilities 2,483 3,076 17,695 22,228 Long-term liabilities: Loans and credit from banks and other lenders 406 453 2,892 3,276 Debentures 960 1,029 6,844 7,433 Deferred tax liabilities 41 46 292 333 Employee benefits 80 106 572 763 Other long-term liabilities 502 308 3,578 2,224 Total long-term liabilities 1,989 1,942 14,177 14,029 Total liabilities 4,472 5,018 31,872 36,257 Equity Total equity 2,944 3,272 20,982 23,645 Total liabilities and equity 7,416 8,290 52,854 59,902 Numbers may not sum due to rounding

Abridged Consolidated Cash Flow Statement for the Second Quarter of 2024 Q2 2024 USD (m) Q2 2023 USD (m) Q2 2024 RMB (m) Q2 2023 RMB (m) Cash flow from operating activities: Cash flow from operating activities 347 405 2,466 2,840 Cash flow from operating activities 347 405 2,466 2,840 Investing activities: Acquisitions of fixed and intangible assets (47) (85) (332) (598) Net cash received from disposal of fixed assets, intangible assets and others 4 1 27 5 Other investing activities (5) 16 (37) 112 Cash flow used for investing activities (48) (69) (342) (482) Financing activities: Receipt of loans from banks and other lenders 21 73 151 510 Repayment of loans from banks and other lenders (198) (200) (1,410) (1,400) Interest payment and other (59) (49) (419) (342) Dividend to shareholders – (9) – (63) Other financing activities (26) (22) (184) (155) Cash flow used for financing activities (262) (207) (1,861) (1,450) Effects of exchange rate movement

on cash and cash equivalents 2 (3) 29 183 Net change in cash and cash equivalents 39 126 292 1,092 Cash and cash equivalents at the beginning of the period 519 506 3,679 3,479 Cash and cash equivalents at the end of the period 557 633 3,971 4,571 Free Cash Flow 245 288 1,740 2,021 Numbers may not sum due to rounding Abridged Consolidated Cash Flow Statement for the First Half of 2024 H1 2024 USD (m) H1 2023 USD (m) H1 2024 RMB (m) H1 2023 RMB (m) Cash flow from operating activities: Cash flow used for operating activities 243 (19) 1,731 -65 Cash flow from (used for) operating activities 243 (19) 1,731 -65

Investing activities: Acquisitions of fixed and intangible assets (113) (170) (800) (1,178) Net cash received from disposal of fixed assets, intangible assets and others 4 4 30 31 Acquisition of subsidiary – (22) – (148) Other investing activities (6) 25 (45) 175 Cash flow used for investing activities (115) (162) (815) (1,121) Financing activities: Receipt of loans from banks and other lenders 193 598 1,369 4,105 Repayment of loans from banks and other lenders (393) (229) (2,792) (1,599) Interest payments and other (83) (75) (587) (522) Dividend to shareholders – (9) – (63) Other financing activities 23 (75) 165 (520) Cash flow from (used for) financing activities (260) 210 (1,845) 1,401 Effects of exchange rate movement on cash and cash equivalents 2 (2) 42 130 Net change in cash and cash equivalents (129) 26 (886) 345 Cash and cash equivalents at the beginning of the period 686 607 4,857 4,225 Cash and cash equivalents at the end of the period 557 633 3,971 4,571

Free Cash Flow 51 (254) 364 (1,689) Numbers may not sum due to rounding Notes to Abridged Consolidated Financial Statements Note 1: Basis of preparation Basis of presentation and accounting policies: The abridged consolidated financial statements for the quarters ended June 30, 2024 and 2023 incorporate the financial statements of ADAMA Ltd. and of all of its subsidiaries (the “Company”), including Adama Agricultural Solutions Ltd. (“Solutions”) and its subsidiaries. The Company has adopted the Accounting Standards for Business Enterprises (ASBE) issued by the Ministry of Finance (the “MoF”) and the implementation guidance, interpretations and other relevant provisions issued or revised subsequently by the MoF (collectively referred to as “ASBE”).

The abridged consolidated financial statements contained in this release are presented in both Chinese Renminbi (RMB), as the Company’s shares are traded on the Shenzhen Stock Exchange, as well as in United States dollars ($) as this is the major currency in which the Company’s business is conducted. For the purposes of this release, a customary convenience translation has been used for the translation from RMB to US dollars, with Income Statement and Cash Flow items being translated using the quarterly average exchange rate, and Balance Sheet items being translated using the exchange rate at the end of the period.

* **Estimates and assumptions:** Management uses estimates and assumptions to prepare financial statements. These are often based on historical data, industry trends, and expert judgment. * **Impact on financial statements:** These estimates and assumptions can significantly impact the reported amounts of assets, liabilities, revenues, and expenses.

“Other operating expenses” includes impairment losses (not including inventory impairment); gain (loss) from disposal of assets and non-operating income and expenses “Operating expenses” in this release differ from those in the formally reported financial statements in that certain transportation costs have been reclassified from COGS to Operating Expenses. “Financial expenses” includes net financing expenses and gains/losses from changes in fair value. Abridged Consolidated Balance Sheet: “Other current assets, receivables and prepaid expenses” includes financial assets held for trading; financial assets in respect of derivatives; prepayments; other receivables; and other current assets “Fixed assets, net” includes fixed assets and construction in progress

“Intangible assets, net” includes intangible assets and goodwill “Other non-current assets” includes other equity investments; long-term equity investments; long-term receivables; investment property; and other non-current assets “Loans and credit from banks and other lenders” includes short-term loans and non-current liabilities due within one year “Other current liabilities” includes financial liabilities in respect of derivatives; payables for employee benefits, taxes, interest, dividends and others; advances from customers and other current liabilities “Other long-term liabilities” includes long-term payables, provisions, deferred income and other non-current liabilities Income Statement Adjustments Q2 2024 USD (m) Q2 2023 USD (m) Q2 2024 RMB (m) Q2 2023 RMB (m) Reported Net Loss (94) (46) (667) (325) Adjustments to COGS & Operating Expenses:

1. Amortization of acquisition-related PPA and other acquisition related costs 4 4 28 29 2. Amortization of Transfer assets received and written-up due to 2017 ChemChina- Syngenta transaction (non-cash) 5 5 36 33 3. Accelerated depreciation 1 1 6 5 4. Incentive plans – (4) – (25) 5. ASBEs classifications COGS impact (29) (24) (208) (165) 6. ASBEs classifications OPEX impact 29 24 208 165 7. Measures to improve efficiencies 4 – 26 – 8. Provisions such as legal claims, registration impairment and ?update of registration depreciation – 44 – 312 – 9. Soil cleanup and remediation 11 – 78 – Total Adjustments to Operating Income (EBIT) 69 6 488 42 Total Adjustments to EBITDA 44 (3) 312 (23) Adjustments to Financing Expenses:

10. Non-cash adjustment related to put option revaluation (34) – (239) – Other financing expenses 7 – 48 – Adjustments to Taxes: Taxes impact 9 1 62 5 Total adjustments to Net loss 33 5 235 37 Adjusted Net Loss (61) (41) (432) (288) H1 2024 USD (m) H1 2023 USD (m) H1 2024 RMB (m) H1 2023 RMB (m) Reported Net loss (126) (34) (895) (242) Adjustments to COGS & Operating Expenses: 1. Amortization of acquisition-related PPA and other acquisition related costs 8 8 54 58 2. Amortization of Transfer assets received and written-up due to 2017 ChemChina-Syngenta transaction (non-cash) 10 11 72 74 3. Accelerated depreciation 2 1 12 10 4. Incentive plans – (4) – (31) 5. ASBEs classifications COGS impact (59) (53) (421) (368) 6. ASBEs classifications OPEX impact 59 53 421 368 7. Measures to improve efficiencies 15 – 107 – 8. Provisions such as legal claims, registration impairment and

1. Repayment of Debt. (20) 2. Leasehold Improvements.

When a company acquires another company, it needs to account for the purchase price. This price includes the fair market value of the acquired company’s assets, liabilities, and equity. The purchase price is then allocated to the acquired company’s identifiable assets and liabilities. This process is known as the Purchase Price Allocation (PPA).

Exchange Rate Data for the Company’s Principal Functional Currencies June 30 Q2 Average H1 Average 2024 2023 Change 2024 2023 Change 2024 2023 Change EUR/USD 1.069 1.086 -1.53 % 1.076 1.09 -1.17 % 1.081 1.081 0.03 % USD/BRL 5.559 4.819 -15.35 % 5.217 5.56 6.15 % 5.085 5.073 -0.24 % USD/PLN 4.032 4.107 1.82 % 3.997 4.18 4.33 % 3.994 4.285 6.78 % USD/ZAR 18.448 18.657 1.12 % 18.576 18.65 0.39 % 18.736 18.192 -2.99 % AUD/USD 0.663 0.663 0.09 % 0.659 0.67 -1.50 % 0.658 0.676 -2.65 % GBP/USD 1.264 1.262 0.11 % 1.262 1.26 -0.03 % 1.265 1.233 2.61 % USD/ILS 3.759 3.700 -1.59 %

3.732 3.70 -0.86 % 3.696 3.592 -2.90 % USD L 3M 5.32 % 3.40 % 1.92 bp 5.33 % 3.08 % 2.25 bp 5.32 % 2.65 % 2.67 bp June 30 Q2 Average H1 Average 2024 2023 Change 2024 2023 Change 2024 2023 Change USD/RMB 7.127 7.226 -1.37 % 7.108 7.009 1.41 % 7.105 6.925 2.60 % EUR/RMB 7.622 7.848 -2.88 % 7.650 7.633 0.22 % 7.681 7.484 2.63 % RMB/BRL 0.780 0.667 -16.95 % 0.734 0.706 -3.90 % 0.716 0.733 2.30 % RMB/PLN 0.568 0.568 0.00 % 0.596 0.596 0.00 % 0.619 0.619 0.00 % RMB/ZAR 0.386 0.387 0.26 %

0.383 0.376 -1.81 % 0.381 0.381 0.00 % AUD/RMB 4.727 4.788 -1.28 % 4.683 4.688 -0.10 % 4.678 4.683 -0.12 % GBP/RMB 9.007 9.121 -1.26 % 8.969 8.776 2.20 % 8.989 8.538 5.28 % RMB/ILS 0.527 0.512 -3.01 % 0.525 0.520 -0.96 % 0.520 0.519 -0.30 % RMB Shibor 3M 1.917 % 2.17 % -0.253 bp 1.991 % 2.292 % -0.301 bp 2.135 % 2.352 % -0.217 bp Forward looking statement: This press release published by ADAMA Ltd. or ADAMA Agricultural Solutions Ltd. (together the “Company”) is for marketing and information purposes only, and contains forward-looking statements which are based on Company’s management’s beliefs and assumptions and on information currently available to the Company’s management. By this press release, the Company does not intend to give, and the press release does not constitute, professional or business advice or an offer or recommendation to perform any transaction in the Company’s securities. The accuracy, completeness and/or adequacy of the content of this press release, as well as any estimation and/or assessment included in this press release, if at all, is not warranted or guaranteed and the Company disclaims any intention and/or obligation to comply with such content. The Company shall not be liable for any loss, claim, liability or damage of any kind resulting from your reliance on, or reference to, any detail, fact or opinion presented herein. The Company’s assessments are based on the information available to the Company as of the date hereof, and may not be realized or be realized in a different manner than the Company estimates, inter alia, due to factors out of the Company’s control, including the risk factors listed in the Company’s annual reports, changes in the industry or potential operations of the Company’s competitors. Any content contained herein shall not constitute or be construed as any regulatory, valuation, legal, tax, accounting and investment advice or any advice of any kind or any part of it, nor shall they constitute or be construed as any recommendation, solicitation, offer or commitment (or any part of it) to buy, sell, subscribe for or underwrite any securities, provide any credit or insurance or engage in any transactions. Before entering into any transactions, you shall ensure that you fully understand the potential risks and returns of such transactions. Before making such decisions, you shall consult the advisors you think necessary, including your accountant, investment advisor and legal and tax specialists. The Company and its affiliates, controlling persons, directors, officials, partners, employees, agents, representatives or their advisors shall not assume any responsibilities of any kind (including negligence or others) for the use of and reliance on such information by you or any person to whom such information are provided.

[1] CER – Constant Exchange Rates [2] Sources: CCPIA (China Crop Protection Industry Association), BAIINFO, FocusEconomics, China ?Containerized Freight Index, internal sources [3] For an analysis of the differences between the adjusted income statement items and the income statement items as reported in the financial statements, see below “Analysis of Gaps between Adjusted Income Statement and Income Statement in Financial Statements”. [4] The number of shares used to calculate both basic and diluted earnings per share in both Q2 2024 and 2023 is 2,329.8 million shares. [5] For an analysis of the differences between the adjusted income statement items and the income statement items as reported in the financial statements, see below “Analysis of Gaps between Adjusted Income Statement and Income Statement in Financial Statements”.

[6] The number of shares used to calculate both basic and diluted earnings per share in both H1 2024 and 2023 is 2,329.8 million shares. Logo – https://mma.prnewswire.com/media/799829/Adama_Agricultural_Solutions_Logo.jpg SOURCE ADAMA Ltd.